Official sources are linked where cited · Preliminary guidance; no qualified legal or regulatory review. Editorial method and review status
FDA NOTIFICATION
Plan the 30-day notification without treating it as approval
Section 403(r)(6) requires a manufacturer that markets a dietary supplement with a covered statement to notify FDA no later than 30 days after first marketing the product with that statement. The notification is not product approval.
FDA currently encourages electronic notifications through its Centralized Online Submission Module (COSM). Use FDA’s instructions and your own account; this website does not submit a notification or log in for you.
Confirm the route: covered structure/function, general well-being and classical nutrient-deficiency claims use this notification pathway. Health and nutrient-content claims have different requirements.
Prepare the manufacturer/packer/distributor name and address, exact statement, relevant dietary ingredient or supplement, and every product and brand using the statement. Do not substitute “other products” for a product list.
Obtain the responsible individual’s signature and certification: complete and accurate notice, with substantiation that the statement is truthful and not misleading. A submission is not a substitute for the substantiation file.
Follow the current COSM guide, review the complete notification before submission, and retain the submitted copy, receipt confirmation and any status email with the artwork version and first-marketing evidence.
Monitor any FDA correspondence. FDA generally does not send a response when it has no objection; silence or a receipt is not claim approval or a complete compliance review.
This section was checked against official source text on October 25, 2026; eCFR provisions use the October 22, 2026 snapshot. Examples explain a preparation task and are not product approval.
A notification packet is more than a date
Record
Fictional example or required evidence
Exact statement and product
Retain the final wording, dietary ingredient or supplement identity, and product/brand name; do not submit only a broad benefit category.
First marketing and planning date
Example first marketing: 2026-12-15. Thirty calendar days later: 2027-01-14. Keep evidence for the first date; the calculation does not establish eligibility.
Submitting party and certification
Check the manufacturer, packer or distributor information and the signed completeness, accuracy and substantiation certification in 101.93(a). Follow current FDA submission instructions.
Identify the exact statement: preserve the claim wording and every linked qualifier.
Classify the statement: determine whether it is a covered dietary supplement statement rather than assuming every marketing sentence uses the same route.
Establish first marketing: record when the product was first marketed with that statement and retain the evidence used for the date.
Identify the responsible manufacturer: confirm the party that must submit and the information required in the notification.
Review the filing method: follow current FDA submission instructions and retain the submission record.
What the 30-day period means
The statutory language is “no later than 30 days after” first marketing with the statement. It is not a general thirty-day premarket waiting period. A calendar calculation also does not decide whether the statement qualifies, whether the submitted record is complete, or how FDA will view the claim.
Records to keep together
Final label or labeling showing the complete statement and disclaimer relationship.
First-marketing date and the evidence supporting that date.
Product and manufacturer identity used in the submission.
Substantiation file for the statement.
Submission copy, confirmation, later amendments, and claim withdrawal history.